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              H
YPERTENSION, dyslipidemia, and diabetes are estab-
lished risk factors for cardiovascular disease (CVD) 
morbidity and mortality (  1  ). Adults aged 65 and older are dis-
proportionately affected by these factors, and although they 
make up only 12% of the total United States (U.S.) popula-
tion, they incur 62% of national health care expenses for heart 
conditions (  2  ,  3  ). CVD risk reduction strategies among older 
adults can lead to a decline in premature CVD morbidity and 
mortality (  4    –    7  ). However, the past decade has shown a gen-
eral increase in CVD risk factors in this population along with 
suboptimal control rates. CVD mortality remains the number 
one cause of death among adults aged 65 and older, account-
ing for 31% of all deaths in this age group in 2003 (  8    –    11  ). 
  The prevalence and management (treatment and control) of 
cardiovascular risk factors among elderly people aged 65 and 
older has not been well described, yet this population will 
nearly double from 37 million in 2005 to 72 million in 2030 
(  2  ,  12  ) presenting challenges to the Centers for Medicare and 
Medicaid Services, which provides the primary health insur-
ance program, Medicare, to most of these adults. Knowledge 
of the current magnitude of hypertension, dyslipidemia, and 
diabetes in this population is important for health care resource 
allocation, disease management, and education (  13  ,  14  ). 
  The National Health and Nutrition Examination Survey 
(NHANES) is a nationally representative survey of nonin-
stitutionalized adults providing data on a wide variety of 
health conditions through in-person interviews at home, fol-
lowed by clinical examinations and laboratory tests in a mo-
bile examination center (  15  ). 
  This study presents national-level data from the NHANES 
1999  –  2004 to estimate the prevalence, awareness, pharmaco-
logic treatment, and control of hypertension, dyslipidemia, 
and diabetes among adults 65 years of age and older. A num-
ber of publications have used the NHANES 2003  –  2004 data 
to report on aspects of hypertension, high cholesterol, or dia-
betes in selected subpopulations; however, these have not 
speciﬁ  cally addressed awareness, treatment, and control in 
adults  aged  65  and  older  ( 8 , 9 , 16  –  19 ).  Our  study  updates  the 
current literature with analyses of these three cardiovascular 
risk factors, combining the NHANES 2003  –  2004 with the 
NHANES 1999  –  2002 data in order to present a more robust 
sample. Prevalence estimates in this study are based on clini-
cal   examination rather than self-reported data; therefore, 
prevalence rates for each condition include diagnosed and 
undiagnosed disease. We also present predictors of aware-
ness, treatment, and control for these three CVD risk   factors.   
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 Methods  
 Study  Population 
  We analyzed the sample of older adults (65 years of age 
or older,   n   = 3,810) participating in NHANES 1999  –  2004, 
a continuing statistical survey of the noninstitutionalized 
civilian U.S. population, sponsored by the National Center 
for Health Statistics. All study participants have blood pres-
sure measurements taken, whereas those in the NHANES 
morning subset (  n   = 1,556) also have measurements taken 
of fasting plasma glucose and lipids.     
  Study Deﬁ  nitions 
  In accordance with American Diabetes Association criteria 
for epidemiological studies ( 20 ), study participants were con-
sidered to have diabetes if they met one or more of the fol-
lowing conditions: their fasting plasma glucose level was 
  ≥  126 mg/dL, or they reported being told by a physician that 
they had diabetes, or they were taking glucose-lowering med-
ications. A person was considered  “ aware ”  if he/she  responded 
positively to the question,   “  Have you ever been told by a doc-
tor that you have diabetes or sugar diabetes?  ”   Study partici-
pants who reported taking insulin or oral   hypoglycemic 
agents were classiﬁ  ed as   “  treated.  ”   A treated person was 
considered   “  controlled  ”   if HbA1c was less than 7%. 
  Hypertension was deﬁ  ned in accordance with the Sev-
enth report of the Joint National Committee on Prevention, 
Detection, Evaluation, and Treatment of High Blood Pres-
sure (JNC 7) (  7  ). A person was deemed to have hyperten-
sion if the NHANES examination indicated that, based on 
the average of three measurements, the systolic blood pres-
sure (SBP) was   ≥  140 mm Hg, or the diastolic blood pres-
sure (DBP) was   ≥  90 mm Hg, or if he/she reported current 
use of antihypertensive medication. Consequently, a person 
who may have been informed that he/she had hypertension, 
but who was not on medication and who tested normoten-
sive on the day of the examination was not classiﬁ  ed as a 
prevalent case of hypertension. A person with hypertension 
according to the JNC 7 deﬁ   nition  was  considered   “ aware ”   if 
he/she gave a positive response to the question,   “  Have you 
ever been told by a doctor or other health professional that 
you had hypertension, also called high blood pressure?  ”   A 
person with hypertension was classiﬁ   ed  as   “ treated ”   if  he/
she reported taking antihypertensive medication at the time 
of the survey. A treated person was considered   “  controlled  ”   
if his/her average SBP was <140 mm Hg and average DBP 
was <90 mm Hg. 
  Study participants were classiﬁ  ed as having dyslipidemia 
if their low-density lipoprotein (LDL) cholesterol exceeded 
the appropriate risk-based threshold established by the Na-
tional Cholesterol Education Panel (NCEP) Adult Treat-
ment Panel III (ATP III) (  4  ) or if they reported taking an 
antihyperlipidemic drug at the time of the examination. 
Similar to hypertension, this deﬁ  nition excludes persons 
who report having previously been told that they had high 
cholesterol but who test negative in NHANES and are not 
on medication. A person with dyslipidemia according to the 
ATP III deﬁ  nition was considered   “  aware  ”   if he/she gave a 
positive response to the question,   “  Have you ever been told 
by a doctor or other health professional that your blood cho-
lesterol level was high?  ”   Those who reported taking pre-
scribed medicine to lower their blood cholesterol were 
considered   “  treated.  ”   A treated person was classiﬁ  ed  as 
  “  controlled  ”   if his/her LDL was lower than the appropriate 
NCEP-ATP III goal.     
 Data  Analysis 
  We applied survey weights to the NHANES 1999  –  2004 
data to derive population estimates of the prevalence of dia-
betes, hypertension, and dyslipidemia, as well as aware-
ness, treatment, and control rates of these condi    tions 
among persons aged 65 or older. Calculations were 
 Table  1  .       Demographic  Characteristics  of  U.S. Adults  65 Years  of Age 
and Older, National Health and Nutrition Examination Survey 
1999 – 2004  
  Characteristic   N  Weighted % Standard Error   
  S e x  
      Male 1,890 42.7 0.7 
      Female 1,920 57.3 0.7 
 Age  (y)  
      65 – 74 1,942 55.2 1.3 
      75 – 84 1,400 35.3 1.0 
       ≥ 85 468 9.5 0.6 
 Race/ethnicity  
      White,  non-Hispanic 2,344 83.0 1.8 
      Black,  non-Hispanic 570 7.9 1.0 
      Hispanic 828 6.9 1.7 
      Other,  non-Hispanic 68 2.2 0.4 
  Married/living with partner  
      Yes 2,075 58.2 1.4 
      No 1,618 41.8 1.4 
 Education  
      Less  than  high  school 1,659 32.2 1.7 
      High  school  or  more 2,132 67.8 1.7 
  Have usual health care provider  
      Yes 3,615 96.8 0.4 
      No 151 3.2 0.4 
  Doctor visits past year  
      0 209 4.8 0.5 
      1 393 10.5 0.5 
      2 – 3 1,007 27.0 1.1 
      4 – 9 1,395 37.1 1.1 
       ≥ 10 802 20.7 0.9 
  Retiree health insurance  
      Private 304 7.7 0.9 
      Government 1,936 47.1 1.5 
      Both 1,423 44.2 1.5  
None 83 1.0 0.2   M C DONALD  ET  AL.  258
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performed using SAS version 9.1 (SAS Institute Inc., Cary, 
NC, 2004), and standard errors and   p   values computed 
using the procedure SURVEYFREQ, which takes into 
account the effect on estimator variance attributable to the 
complex NHANES multistage stratiﬁ   ed cluster sample 
design. To determine independent risk factors, multivariate 
logistic regression models were estimated incorporating 
covariates for sex, age, usual place of care, doctor visits in 
past year, household income, living with spouse/partner, 
and education level. The models were estimated using the 
SAS SURVEYLOGISTIC procedure.       
 Results 
    Table 1       shows the characteristics of adults aged 65 and 
older in the United States. Based on NHANES 1999  –  2004, 
55.2% are 65  –  74 years old, more than half of all elders are 
married or living with a partner, and virtually all older adults 
are  insured.   
  The overall prevalence of hypertension (  Table 2      ) among 
older adults is 70.8%, with prevalence increasing as age in-
creases. Women have a signiﬁ  cantly higher prevalence of 
hypertension than men (76.6% vs 63.0%) and a signiﬁ  cantly 
lower rate of control on treatment (42.9% vs 57.9%). At 
54.0%, blood pressure control is higher among the youngest 
old (age 65  –  74) compared with 41.7% and 44.6% in the two 
older age groups (ages 75  –  84, ≥85   ),  respectively.  Overall, 
42% of older adults have uncontrolled isolated systolic hy-
pertension (SBP   ≥  140 mm Hg and DBP <90 mm Hg [data 
not shown]). Women have signiﬁ  cantly higher levels than 
men of isolated SBP   ≥  140 mm Hg and <160 mm Hg (28.6% 
vs 22.1%,   p   <.0002) and of isolated SBP of 160 mm Hg or 
greater (21.0% vs 10.1%,   p   < .0001). Isolated systolic hy-
pertension accounts for 88.4% of undiagnosed hypertension 
among older adults.     
  Dyslipidemia prevalence (  Table 2      ) is 60.3% overall. 
Men are signiﬁ  cantly less likely to be aware of their con-
dition than women (59.1% vs 71.1%), although both gen-
ders are equally likely to be treated (40.9% vs 45.1%). 
The oldest old have a signiﬁ  cantly lower prevalence, are 
less aware, and have a lower treatment rate for dyslipi-
demia than the youngest old. Two thirds of all older adults 
medically treated for dyslipidemia reach their LDL 
cholesterol goal. 
  Table 3    .            Logistic Regression Models of Predictors of Awareness, Treatment, and Control of Hypertension Among U.S. Adults 65 Years of Age 
and Older, National Health and Nutrition Examination Survey 1999  –  2004   
   Hypertension   
 Awareness,  OR 
(95% CI) (  N   = 2,190)
Treatment OR 
(95% CI) (  N   = 2,190)
Control Among Treated, 
OR (95% CI) (  N   = 1,391)   
  Sex  
      Female 0.82  (0.62 – 1.09) 0.84  (0.64 – 1.12) 0.51  (0.39 – 0.68)  ‡   tblfn6   
      Male 1.0 1.0 1.0 
 Age  (y)  
      ≥85 0.54  (0.40 – 0.72)  ‡   tblfn6   0.60  (0.45 – 0.81)  ‡   tblfn6   0.68  (0.37 – 1.23) 
      75 – 84 0.71  (0.53 – 0.95) * tblfn4   0.70  (0.52 – 0.94) *  tblfn4   0.59  (0.44 – 0.80)  ‡   tblfn6   
      65 – 74 1.0 1.0 1.0 
 Education  
      High  school  or  more 0.93  (0.70 – 1.23) 0.88  (0.73 – 1.07) 1.18  (0.87 – 1.60) 
      Less  than  high  school 1.0 1.0 1.0 
  Doctor visits past year  
       ≥ 10 5.13  (3.11 – 8.47)  ‡   tblfn6   5.84  (3.62 – 9.41)  ‡   tblfn6   1.48  (0.90 – 2.42) 
      2 – 9 3.83  (2.65 – 5.52)  ‡  tblfn6   4.09  (2.66 – 6.29)  ‡   tblfn6   1.21  (0.75 – 1.97) 
      1  or  none 1.0 1.0 1.0 
  Married/living with partner  
      Yes 0.91  (0.71 – 1.17) 0.96  (0.75 – 1.21) 0.76  (0.54 – 1.07) 
      No 1.0 1.0 1.0 
  Have usual health care provider  
      Yes 2.87  (1.26 – 6.51) * tblfn4   5.10  (2.65 – 9.83)  ‡   tblfn6   0.72  (0.36 – 1.43) 
      No 1.0 1.0 1.0 
 Household  income  
      <$15,000 1.30  (0.89 – 1.89) 1.20  (0.83 – 1.74) 0.91  (0.60 – 1.39) 
      $15,000  to  <$45,000 1.03  (0.74 – 1.43) 0.97  (0.73 – 1.28) 0.92  (0.66 – 1.29) 
       ≥ $45,000 1.0 1.0 1.0  
    Notes:   OR = odds ratio; CI = conﬁ  dence interval.   
  *    p    ≤   .05.  
   ‡     p    ≤   .001.      M C DONALD  ET  AL.  260
  Diabetes (  Table 2      ) affects 21.2% of adults 65 years of age 
and older. The awareness rate for diabetes (71.4%) is driven 
by a signiﬁ  cantly higher awareness among women than 
among men (78.5% vs 63.6%). Half of all prevalent diabe-
tes cases are treated pharmacologically, and only half of all 
treated cases reach HbA1c goal attainment of <7%.   
  Predictors of Awareness, Treatment, and Control 
  Tables  3   ,   4   ,  and   5     present  the  results  of  estimating  sepa-
rate logistic regression models for the rates of awareness, 
pharmacologic treatment, and control of the three  conditions, 
adjusting for the effects of age, sex, education, number of 
doctor visits, living arrangement, having a usual health care 
provider  and  annual  household  income.       
  For elders with hypertension, higher age is associated 
with lower rates of awareness (odds ratio [OR] = 0.71 [age 
75  –  84] and 0.54 [age ≥85] vs age 65  –  74), treatment (OR = 
0.70 [age 75  –  84] and 0.60 [age ≥85] vs age 65  –  74), and 
control (OR = 0.59 [age 75  –  84] vs age 65  –  74). Among 
those with dyslipidemia, the oldest (age ≥85) have signiﬁ  -
cantly lower rates of awareness and treatment (OR = 0.29 
and 0.38 vs age 65  –  74, respectively). Although there are no 
signiﬁ  cant differences between the sexes in awareness or 
treatment for hypertension, women on treatment are only 
half as likely as men to have their blood pressure controlled 
(OR = 0.51). Women are more likely than men to be aware 
and treated for dyslipidemia (OR = 2.60 and 1.56, respec-
tively) and more likely to be aware of their diabetes (OR = 
3.14). There are no signiﬁ  cant associations between educa-
tion (high school or more) and awareness, treatment, or 
control of hypertension and diabetes, however, education is 
positively associated with awareness (OR = 1.39) and treat-
ment (OR = 1.62) of dyslipidemia. The number of doctor 
visits in the past year is positively and strongly associated 
with awareness and treatment of all three conditions. Liv-
ing arrangement (married/living with partner) is not associ-
ated with awareness, treatment, or control of any of the 
conditions. Elders who have a usual health care provider 
are far more likely than those who do not have a usual pro-
vider to be aware (OR = 2.87) and treated (OR = 5.10) for 
their hypertension. Elders with low annual household in-
come (less than $15,000 in 2002 dollars) are much less 
likely than those with income more than $45,000 to be 
  Table 4    .            Logistic Regression Models of Predictors of Awareness, Treatment, and Control of Dyslipidemia Among U.S. Adults Aged 65 and 
Older, National Health and Nutrition Examination Survey 1999  –  2004   
   Dyslipidemia   
 Awareness,  OR 
(95% CI) (  N   = 746)
Treatment, OR 
(95% CI) (  N   = 746)
Control Among Treated, OR 
(95% CI) (  N   = 286)   
  Sex  
      Female 2.60  (1.74 – 3.88)  ‡   tblfn9   1.56  (1.10 – 2.22) * tblfn7   1.19  (0.57 – 2.45) 
      Male 1.0 1.0 1.0 
 Age  (y)  
      ≥85 0.29  (0.14 – 0.58)  ‡   tblfn9   0.38  (0.22 – 0.66)  ‡  tblfn9   1.36  (0.34 – 5.54) 
      75 – 84 0.98  (0.62 – 1.55) 0.91  (0.60 – 1.36) 0.99  (0.53 – 1.84) 
      65 – 74 1.0 1.0 1.0 
 Education  
      High  school  or  more 1.39  (1.03 – 1.87) *  tblfn7   1.62  (1.19 – 2.22)  †  tblfn8   1.26  (0.84 – 1.89) 
      Less  than  high  school 1.0 1.0 1.0 
  Doctor visits past year  
       ≥ 10 1.92  (1.09 – 3.37) *  tblfn7   3.27  (1.59 – 6.73)  †  tblfn8   2.93  (1.03 – 8.33) *  tblfn7   
      2 – 9 1.89  (1.16 – 3.10) *  tblfn7   4.14  (2.33 – 7.36)  ‡  tblfn9   5.50  (2.29 – 13.21)  ‡   tblfn9   
      1  or  none 1.0 1.0 1.0 
  Married/living with partner  
      Yes 1.40  (0.78 – 2.51) 1.42  (0.88 – 2.31) 0.99  (0.44 – 2.23) 
      No 1.0 1.0 1.0 
  Have usual health care provider  
      Yes 2.49  (0.99 – 6.27) 1.85  (0.53 – 6.43) 0.81  (0.29 – 2.22) 
      No 1.0 1.0 1.0 
 Household  income  
      <$15,000 0.36  (0.23 – 0.56)  ‡   tblfn9   0.61  (0.32 – 1.15) 0.39  (0.16 – 0.96) *  tblfn7   
      $15,000  to  <$45,000 0.73  (0.48 – 1.12) 1.38  (0.79 – 2.41) 0.62  (0.32 – 1.20) 
       ≥ $45,000 1.0 1.0 1.0  
    Notes:   OR = odds ratio; CI = conﬁ  dence interval.   
  *    p    ≤   .05.  
   †     p    ≤   .01.  
   ‡     p    ≤   .001.      CARDIOVASCULAR CONDITIONS IN ELDERS  261
aware or controlled on treatment for their dyslipidemia 
(OR = 0.36 and 0.39, respectively). Those in the middle-
income range of $15,000  –  $45,000 are less likely than per-
sons with household income more than $45,000 to be aware 
of their diabetes (OR = 0.36).       
 Discussion 
  Using the combined NHANES 1999  –  2004 data, these 
analyses provide up-to-date estimates of prevalence, aware-
ness, treatment, and control of hypertension, dyslipidemia, 
and diabetes among adults aged 65 and older in the United 
States. Our results are consistent with previous studies of 
prevalence of these three cardiovascular risk factors in older 
adults  ( 8  –  10 , 16 , 17 );  expand  the  body  of  knowledge  regard-
ing awareness, treatment, and control rates; and identify 
gender disparities among the rates. 
  We found that older women are more likely than older 
men to have hypertension, equally likely to be aware and 
treated, but less likely to have their blood pressure con-
trolled on pharmacotherapy. Older women have a higher 
prevalence than men of isolated systolic hypertension. Ap-
proximately half of all older adults treated for hypertension 
achieve blood pressure control. This ﬁ  nding is consistent 
with recent studies showing a positive trend of increasing 
blood pressure control among older adults (age ≥60) in the 
NHANES study population (  18  ,  21  ). The improvement in 
control may be due, in part, to physician education and 
changing practice patterns based on the JNC 7 guidelines 
(  7  ). Notwithstanding this success, in the present study, 
women are only half as likely as men (after adjusting for 
covariates) to attain blood pressure goal. A similar ﬁ  nding 
for women (age ≥20) was reported in a previous NHANES 
1999  –  2002 study of racial disparities in hypertension, after 
adjusting for race (  22  ), suggesting that additional blood 
pressure control programs speciﬁ   cally targeted toward 
women are warranted. The paradigm shift of the JNC em-
phasizing the importance of diagnosing and treating systolic 
hypertension  among  older  adults  ( 23 , 24 )  further  merits  the 
need for such gender-speciﬁ  c programs. 
  We found the prevalence of dyslipidemia to be similar by 
gender, with women more likely to be aware and treated. 
Although overall treatment is only 43%, there has been a 
suggestive upward trend of pharmacological treatment for 
  Table 5    .            Logistic Regression Models of Predictors of Awareness, Treatment, and Control of Diabetes Among U.S. Adults Aged 65 and Older, 
National Health and Nutrition Examination Survey 1999  –  2004   
   Diabetes   
 Awareness,  OR 
(95% CI) (  N   = 284)
Treatment, OR 
(95% CI) (  N   = 284)
Control Among Treated, OR 
(95% CI) (  N   = 498)   
  Sex  
      Female 3.14  (1.59 – 6.18)  ‡   tblfn12   1.59  (0.81 – 3.08) 1.00  (0.60 – 1.66) 
      Male 1.0 1.0 1.0 
 Age  (y)  
      ≥85 2.20  (0.66 – 7.35) 0.91  (0.38 – 2.21) 2.16  (0.79 – 5.91) 
      75 – 84 0.60  (0.28 – 1.26) 0.87  (0.45 – 1.66) 1.43  (0.87 – 2.35) 
      65 – 74 1.0 1.0 1.0 
 Education  
      High  school  or  more 1.30  (0.64 – 2.64) 0.69  (0.38 – 1.28) 1.66  (0.92 – 2.97) 
      Less  than  high  school 1.0 1.0 1.0 
  Doctor visits past year  
       ≥ 10 7.24  (3.02 – 17.33)  ‡   tblfn12   7.56  (2.29 – 24.91)  ‡   tblfn12   0.34  (0.07 – 1.64) 
      2 – 9 1.95  (0.93 – 4.09) 3.59  (1.26 – 10.22) *  tblfn10   0.37  (0.08 – 1.80) 
      1  or  none 1.0 1.0 1.0 
  Married/living with partner  
      Yes 1.71  (0.83 – 3.52) 1.02  (0.47 – 2.25) 0.72  (0.44 – 1.17) 
      No 1.0 1.0 1.0 
  Have usual health care provider  
      Yes 0.57  (0.09 – 3.54) 1.43  (0.24 – 8.63) 1.51  (0.30 – 7.70) 
      No 1.0 1.0 1.0 
 Household  income  
      <$15,000 0.67  (0.21 – 2.20) 0.52  (0.20 – 1.36) 0.75  (0.37 – 1.51) 
      $15,000  to  <$45,000 0.36  (0.15 – 0.85) *  tblfn10   0.49  (0.23 – 1.05) 0.81  (0.44 – 1.49) 
       ≥ $45,000 1.0 1.0 1.0  
    Notes:   OR = odds ratio; CI = conﬁ  dence interval.   
  *    p    ≤   .05.  
   ‡     p    ≤   .001.      M C DONALD  ET  AL.  262
dyslipidemia among older adults (age ≥60), based on esti-
mates from the NHANES data (  16  ). This trend may be at-
tributed to some degree, to increasing adoption of the NCEP 
guidelines (  4  ). Control rates for dyslipidemia in this study 
are similar by gender and by age groups. 
  Our study found that women with diabetes are more 
likely than men to be aware of their condition and that only 
50% of patients on pharmacotherapy are controlled 
(HbA1c <7%). Other studies in various clinical settings 
have documented poor diabetes control among the elderly 
adults (  25  ,  26  ). This study provides newer evidence that 
conﬁ  rms the need for improved quality of care. 
  In our study, treatment and goal attainment rates for all 
three conditions are suboptimal. Continued physician ef-
forts to improve treatment rates and successfully treat pa-
tients to goal are needed. Although our study shows that 
increasing numbers of doctor visits are associated with 
awareness and treatment for all three conditions, and with 
goal attainment for dyslipidemia, the interpretation of this 
ﬁ  nding is ambiguous. It may be that more frequent visits 
provide added opportunity for physicians to detect and treat 
undiagnosed disease, or the causality may be reversed, and 
those who already are aware and/or treated make more vis-
its for the purpose of reﬁ  lling prescriptions or monitoring 
treatment effectiveness. The reasons for the visits cannot be 
determined using the NHANES data. 
  An important national public health effort to reduce CVD 
risk factor burden through the   Healthy People 2010   has had 
ongoing successes (  16  ,  27  ), and knowledge of our study’s 
ﬁ  ndings on gender differences in awareness and control 
may be useful to clinicians in the effort to improve out-
comes. 
  The strengths of this study include its population-based 
sampling frame and the availability of clinical measurements 
to determine undiagnosed and diagnosed disease prevalence 
and to determine goal attainment. Additionally, using 6 years 
of NHANES data provides a large sample and precise esti-
mates of conditions affecting older adults. To our knowl-
edge, this is the ﬁ  rst study to use NHANES 1999  –  2004 to 
report on the prevalence and management of CVD risk fac-
tors among adults 65 years and older. Such information may 
be helpful to health care decision makers. A limitation in our 
study is that physician-speciﬁ  c variables, such as practitioner 
age, group practice size and setting (eg, university medical 
center), and practice patterns are not available in NHANES. 
It is also likely that we overestimated blood pressure control 
rates. We used a blood pressure goal of <140/90 mm Hg for 
adults with hypertension with and without diabetes, a method 
that has been applied in other studies ( 8 , 9 ). The current blood 
pressure goal for adults with hypertension and with diabetes 
is <130/80 mm Hg (  7  ). Applying this threshold to adults 
with hypertension and with diabetes would result in a lower 
estimate of blood pressure control (  7  ,  9  ). 
  Our study provides insight into a number of controllable 
risk factors affecting the U.S. population of adults 65 years 
and older. This population has a high prevalence of hyper-
tension, dyslipidemia, and diabetes. Women with hyperten-
sion are disproportionately affected by higher prevalence 
and lower control rates than men. Women with dyslipidemia 
or diabetes are more likely than men to be aware of their 
condition. Understanding gaps in awareness can lead to im-
proved treatment rates. For all three conditions, improve-
ments in treatment and control rates are needed. In light of 
the expected growth in this population, patient education 
and targeted efforts to improve disease management are 
clearly  indicated.     
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